Rex Bionics (Rex Bionics) FCF Yield % : 13.11 (As of May. 05, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Rex Bionics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Rex Bionics's Trailing 12-Month Free Cash Flow is $0.00 Mil, and Market Cap is $0.00 Mil. Therefore, Rex Bionics's FCF Yield % for today is 13.11%.

The historical rank and industry rank for Rex Bionics's FCF Yield % or its related term are showing as below:

RXRBY' s FCF Yield % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0
Current: 13.11

RXRBY's FCF Yield % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -2.685 vs RXRBY: 13.11

Rex Bionics's FCF Margin % for the quarter that ended in Mar. 2018 was 0.00%.

Rex Bionics FCF Yield % Historical Data

The historical data trend for Rex Bionics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rex Bionics FCF Yield % Chart

Rex Bionics Annual Data

Trend

Nov13

Mar16

Mar17

Mar18

FCF Yield %

Rex Bionics Semi-Annual Data
	May13	Nov13	May14	Sep15	Mar16	Sep16	Mar17	Mar18
FCF Yield %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Rex Bionics's FCF Yield %

For the Medical Devices subindustry, Rex Bionics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rex Bionics's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rex Bionics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Rex Bionics's FCF Yield % falls into.

Rex Bionics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Rex Bionics's FCF Yield % for the fiscal year that ended in Mar. 2018 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	0.082	/	0
	=	N/A%

Rex Bionics's annualized FCF Yield % for the quarter that ended in Mar. 2018 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	2	/	0
	=	N/A%

Rex Bionics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Rex Bionics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Rex Bionics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rex Bionics (Rex Bionics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rex Bionics PLC (OTCPK:RXRBY) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.rexbionics.com

Rex Bionics PLC, formerly known as Union MedTech PLC, was incorporated and domiciled in england and Wales on February 27, 2012. The Company is engaged in the research & development, manufacturing and commercialisation of robotic devices designed to provide physiotherapy to and improve the physical and psychological well-being of people with mobility impairment as a result of spinal cord injury or other neurological damage. It provides independent mobility to wheelchair users and other mobility impaired persons using robotic technology, custom-designed electromechanical actuators, precision engineering, and specialised networking systems.The Company's REX devices are REX Rehab and REX Personal.

Rex Bionics (Rex Bionics) Headlines

No Headlines